CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.4348
-0.0050 (-1.14%)
At close: May 18, 2026, 4:00 PM EDT
0.4039
-0.0309 (-7.11%)
After-hours: May 18, 2026, 5:54 PM EDT
CollPlant Biotechnologies Stock Forecast
CLGN's stock price has decreased by -74.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CollPlant Biotechnologies stock has a target of 11.12, which predicts a 2,457.50% increase from the current stock price of 0.43.
Price Target: $11.12 (+2,457.50%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 21, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for CollPlant Biotechnologies is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 6, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +2,659.89% | Nov 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +2,659.89% | Oct 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +2,659.89% | Sep 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +2,429.90% | Aug 21, 2025 |
Financial Forecast
Revenue This Year
8.07M
from 2.37M
Increased by 240.45%
Revenue Next Year
11.14M
from 8.07M
Increased by 38.03%
EPS This Year
-0.42
from -0.94
EPS Next Year
-0.03
from -0.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.5M | 20.3M | |
| Avg | 8.1M | 11.1M | |
| Low | 2.0M | 2.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 512.3% | 151.7% | |
| Avg | 240.4% | 38.0% | |
| Low | -17.3% | -69.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.11 | 0.18 | |
| Avg | -0.42 | -0.03 | |
| Low | -0.72 | -0.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.